Photo-thermal responsive multifunctional hydrogel as well as preparation method and application thereof
By using photothermal-responsive multifunctional hydrogel in bone tumor treatment, combined with specific raw materials and preparation methods, the shortcomings of existing materials in degradability, anti-tumor recurrence and bone tissue repair are solved, and a suitable degradation cycle is achieved. It is biocompatible, inhibits tumor recurrence and promotes bone tissue repair, improving treatment effect.
Patent Information
- Application Number
- CN202411177633.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-11-26
AI Technical Summary
The existing bone tumor treatment materials have insufficient degradability, anti-tumor recurrence, bone tissue repair strength and biocompatibility, resulting in unsatisfactory treatment effects and side effects, especially in cancer patients with poor defect repair results.
Develop a photothermal-responsive multifunctional hydrogel, which is prepared by specific mass ratios and preparation methods using chitosan, alginate, hyaluronate, manganese dioxide, glucose oxidase and polymerized dopamine as raw materials. Combined with low-temperature photothermal therapy, tumor targeting and bone tissue repair are achieved.
The hydrogel has the functions of suitable degradation cycle, biocompatibility, inhibiting tumor recurrence and promoting bone tissue repair. It achieves continuous release of mild temperature through photothermal response, reduces side effects, and improves therapeutic effects.
Smart Images

Figure CN119015504A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biomedical materials, and specifically relates to a photothermal responsive multifunctional hydrogel and a preparation method and application thereof. Background Art
[0002] Osteosarcoma is the most common malignant bone tumor, characterized by high invasiveness, early distal metastasis, and frequent tumor recurrence. Bone tumor treatment is mainly based on surgery, assisted by radiotherapy and chemotherapy. In clinical practice, large sections of bone tissue and surrounding soft tissue need to be removed. Due to tumor erosion and extensive resection, soft and hard tissue defects are common in cancer patients, leading to physical dysfunction, prolonged healing time, and chronic pain. Solving this dilemma is crucial to improving the quality of life of patients, making tissue defect repair and functional reconstruction the focus of current research. Due to complex microstructure, unpredictable surgical complexity, severe tissue rejection, secondary injury, and limited repair capacity, bone defect repair strategies (including prosthesis implantation and various bone transplant sources) are often unsatisfactory, especially in the case of large bone defects in cancer patients.
[0003] Bone replacement materials used for implantation currently mainly include metal scaffolds and degradable polymer scaffold materials. Existing implant materials often have the following defects: (1) The degradability of the implant material cannot adapt to the regeneration rate of the patient's own bone tissue; (2) The implant material may not be able to inhibit tumor recurrence, etc., leading to a series of subsequent problems; (3) It is impossible to achieve both anti-tumor treatment and promotion of bone tissue repair; (4) The implant material is not strong enough and is not suitable for providing a scaffold for bone tissue repair.
[0004] Therefore, there is an urgent need to develop unique biomaterial-based tissue engineering technologies for in situ bone regeneration. Studies have found that the use of scaffold materials, especially biomimetic hydrogels with 3D network structures (Y. Yang, W. Wang, Q. Zeng, N. Wang, W. Li, B. Chen, Q. Guan, C. Li, W. Li, Fabricating oxygen self-supplying 3D printed bioactive hydrogel scaffold for augmented vascularized bone regeneration, Bioact Mater 40 (2024) 227-243) is expected to solve this problem. Hydrogels have the ability to absorb water, provide nutrition, and create a suitable biochemical / mechanical environment for cell adhesion, proliferation and differentiation. In addition, hydrogels facilitate the delivery of functional agents and the sustained release of drug molecules, making them superior materials for tissue engineering, cell culture, drug delivery and anti-tumor therapy. However, hydrogels in the prior art have problems such as low mechanical strength, unsatisfactory therapeutic effect, poor biocompatibility, and single function, which need further improvement. Summary of the invention
[0005] The purpose of the present invention is to provide a photothermal responsive multifunctional hydrogel and a preparation method and use thereof. The hydrogel of the present invention can be used to meet various application requirements such as in situ bone tumor treatment and postoperative bone tissue repair.
[0006] The invention provides a photothermal responsive multifunctional hydrogel, which is a hydrogel prepared by using chitosan or its derivatives, alginate, hyaluronate, manganese dioxide@glucose oxidase, polymerized dopamine and calcium salt as raw materials; wherein the manganese dioxide@glucose oxidase is a product prepared by using manganese dioxide and glucose oxidase as raw materials; and the mass ratio of the chitosan or its derivatives, alginate, hyaluronate, manganese dioxide@glucose oxidase, polymerized dopamine and calcium salt is (5-10): (2-5): (0.05-1): (4-8): (0.5-4): (10-50).
[0007] Furthermore, the chitosan derivative is carboxymethyl chitosan, the alginate is sodium alginate, the hyaluronate is sodium hyaluronate, and the calcium salt is calcium chloride.
[0008] Furthermore, the manganese dioxide@glucose oxidase is manganese dioxide@glucose oxidase nanoparticles, and the polymerized dopamine is polymerized dopamine nanoparticles.
[0009] Furthermore, the preparation method of the manganese dioxide@glucose oxidase nanoparticles comprises the following steps: mixing a manganese dioxide nanoparticle solution with a glucose oxidase solution, reacting to obtain manganese dioxide@glucose oxidase nanoparticles, wherein the mass ratio of the manganese dioxide nanoparticles to the glucose oxidase is (4-8):1.
[0010] Furthermore, the mass ratio of the manganese dioxide nanoparticles to the glucose oxidase is 6:1.
[0011] Furthermore, the manganese dioxide nanoparticles are products obtained by the reaction of polycyclic aromatic hydrocarbons and potassium permanganate.
[0012] Furthermore, the mass ratio of the chitosan or its derivative, alginate, hyaluronate, manganese dioxide@glucose oxidase, polymerized dopamine and calcium salt is 8:3.4:0.2:6:1.6:30.
[0013] The present invention also provides a method for preparing the above-mentioned photothermal responsive multifunctional hydrogel, which comprises the following steps:
[0014] (1) mixing chitosan or its derivatives and manganese dioxide@glucose oxidase in an aqueous solution to obtain a first mixed solution;
[0015] (2) mixing alginate and polymerized dopamine in an aqueous solution to obtain a second mixed solution;
[0016] (3) The first mixed solution is mixed with the second mixed solution, and hyaluronate and calcium salt are added to obtain a photothermal responsive multifunctional hydrogel after reaction.
[0017] In the present invention, the aqueous solution includes water, buffer solution and the like.
[0018] The present invention also provides use of the above-mentioned photothermal responsive multifunctional hydrogel in preparing bone tissue repair materials.
[0019] The present invention also provides use of the above-mentioned photothermal responsive multifunctional hydrogel in preparing a drug for treating bone tumors.
[0020] Compared with the prior art, the present invention has the following beneficial effects:
[0021] (1) The hydrogel of the present invention is combined with low-temperature photothermal therapy to cause less stimulation and trauma to the patient;
[0022] (2) The degradation cycle rate of the hydrogel of the present invention is suitable for the bone tissue regeneration rate;
[0023] (3) The hydrogel of the present invention is composed of biocompatible materials, which are almost irritating to the body and can be absorbed and degraded;
[0024] (4) The hydrogel of the present invention has the function of inhibiting tumor recurrence and promoting bone tissue repair.
[0025] The present invention has developed a photoresponsive multifunctional composite hydrogel platform for in situ bone tumor treatment, recurrence prevention and bone reconstruction, which has the following obvious advantages: (1) Encapsulated manganese dioxide@glucose oxidase nanoparticles use the differences in biological characteristics between tumor and normal cells to achieve tumor targeting, selectively destroy tumor energy supply, reduce tumor hypoxia, and enhance photothermal response; (2) Combined with starvation therapy and warm photothermal therapy, synergistically kill tumors and prevent recurrence; (3) Based on the differences in biological characteristics between tumor cells and normal cells, intelligent targeting design, local effects of hydrogels, platform biocompatibility, and safe low-power near-infrared light excitation, side effects are minimized; (4) The continuous release of glucose oxidase@manganese dioxide nanoparticles and long-term maintenance of mild temperature (42°C) during tumor treatment are conducive to ideal osteogenesis, which is of great significance for clinical application. This innovative therapeutic hydrogel platform not only inspires strategies to inhibit tumor growth and prevent postoperative recurrence, but also has important reference value for patients without surgical indications or with individualized needs.
[0026] Obviously, according to the above contents of the present invention, in accordance with common technical knowledge and customary means in the art, without departing from the above basic technical ideas of the present invention, other various forms of modification, replacement or change may be made.
[0027] The above contents of the present invention are further described in detail below through specific implementation methods in the form of embodiments. However, this should not be understood as the scope of the above subject matter of the present invention being limited to the following examples. All technologies realized based on the above contents of the present invention belong to the scope of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 The figure is a flow chart of the preparation of the photothermal responsive multifunctional hydrogel of the present invention.
[0029] Figure 2 This is a real picture of the photothermal responsive multifunctional hydrogel prepared by the present invention.
[0030] Figure 3 This is a SEM image of the photothermal responsive multifunctional hydrogel prepared in the present invention.
[0031] Figure 4 This is a photothermal warming thermal imaging picture of the photothermal responsive multifunctional hydrogel prepared by the present invention, which is photographed and recorded every 30 seconds.
[0032] Figure 5 Live and dead staining results of K7M2 mouse bone tumor cells were processed for each group of samples.
[0033] Figure 6 ALP staining and ARS staining results of mouse bone marrow mesenchymal stem cells (BMSCs) and osteoblast precursor cells (3T3) treated with hydrogels in each group.
[0034] Figure 7 Shown are the cytotoxicity CCK8 test results of each group of hydrogels. DETAILED DESCRIPTION
[0035] The raw materials and equipment used in the specific embodiments of the present invention are all known products and are obtained by purchasing commercially available products.
[0036] Glucose Oxidase (GO) X .
[0037] Polycyclic aromatic hydrocarbons (PAH) were purchased from Sigma-Aldrich, St Louis, MO, USA.
[0038] Gel, referred to as gel.
[0039] Example 1. Preparation of the photothermal responsive multifunctional hydrogel of the present invention
[0040] The preparation flow chart of the photothermal responsive multifunctional hydrogel of the present invention is as follows Figure 1 shown.
[0041] 1. Preparation of manganese dioxide@glucose oxidase nanoparticles:
[0042] 74.8 mg of PAH was added to 2 mL of deionized water. Then, the PAH solution was added dropwise to a centrifuge tube containing 63 mg of potassium permanganate and 18 ml of deionized water. It was allowed to stand at room temperature for 10 minutes until the purple solution was converted into a brown solution. It was then treated with ultrasound for 10 min and washed three times with deionized water ultracentrifugation technology (50k rpm, centrifugation for 1 h) to obtain MnO2 nanoparticles.
[0043] 10 mL of MnO2 nanoparticle (3 mg / mL) aqueous solution was mixed with 500 μL of GOx solution (1 mg / mL) and placed at room temperature for 20 min to obtain manganese dioxide@glucose oxidase nanoparticles, namely GOx / MnO2 (GM for short) nanoparticles.
[0044] 2. Preparation of polymerized dopamine nanoparticles:
[0045] First, add a mixed solution of 90 mL of deionized water and 40 mL of anhydrous ethanol into a 500 mL beaker. Slowly add 2 mL of ammonia solution (25 wt%) into the prepared mixed solution while gently stirring. Then add 50 mg / ml dopamine solution (10 ml) into the mixed solution by gradual dropwise addition and stir magnetically at room temperature for 24 h. Finally, wash the obtained product with deionized water three times, centrifuge (12k rpm) for 10 min, and then freeze-dry to obtain a black solid, i.e., polymerized dopamine nanoparticles.
[0046] 3. Preparation of hydrogel
[0047] The carboxymethyl chitosan aqueous solution (8 wt %) and the manganese dioxide@glucose oxidase nanoparticle aqueous dispersion (6 wt %) were mixed at a volume ratio of 1:1 to obtain a first mixed solution.
[0048] A sodium alginate aqueous solution (4 wt %) and a polymerized dopamine nanoparticle aqueous dispersion (10 wt %) were mixed at a volume ratio of 800:60 to obtain a second mixed solution.
[0049] 2 mL of the first mixed solution and 1 mL of the second mixed solution were mixed evenly, and then mixed with 200 μl of sodium hyaluronate aqueous solution (1 wt%) to obtain a homogeneous mixed solution. The homogeneous mixed solution was added with 10 mL of calcium chloride solution (3 wt%), and cross-linked under the action of calcium ions. After cross-linking for 24 hours, a hydrogel system was formed, which was the photothermal responsive multifunctional hydrogel of the present invention (referred to as CHA-GOx / MnO2-PDAgel or Gel / PDA-GM).
[0050] The hydrogel system prepared above exhibits a uniform black color, which is due to the black color of the polydopamine and manganese dioxide nanoparticles in the system. Figure 2 shown.
[0051] After freeze-drying, the hydrogel system prepared above was observed using a scanning electron microscope (SEM). Figure 3 As shown: Under SEM, the hydrogel surface presents a porous structure, and the deposited polydopamine particles can be seen under a high-power microscope.
[0052] The following is the preparation method of the control sample:
[0053] Control Example 1: Preparation of CHA gel
[0054] Referring to step 3 of Example 1, the only difference is that the aqueous dispersion of polymerized dopamine nanoparticles and the aqueous dispersion of manganese dioxide@glucose oxidase nanoparticles are not added to obtain CHA gel.
[0055] Control Example 2: Preparation of Gel / PDA
[0056] Referring to step 3 of Example 1, the only difference is that the manganese dioxide@glucose oxidase nanoparticle aqueous dispersion is not added to obtain Gel / PDA gel.
[0057] Control Example 3: Preparation of Gel-GM
[0058] Referring to step 3 of Example 1, the only difference is that no polymerized dopamine nanoparticle aqueous dispersion is added to obtain Gel-GM gel.
[0059] Comparative Example 4: Preparation of Gel / PDA-MnO2 gel
[0060] Refer to step 3 of Example 1, except that the manganese dioxide@glucose oxidase nanoparticle aqueous dispersion is replaced with MnO2 nanoparticle aqueous dispersion to obtain Gel / PDA-MnO2 gel.
[0061] The beneficial effects of the present invention are demonstrated below through specific test examples.
[0062] Experimental Example 1: Test of controllable photothermal performance of the photothermal responsive multifunctional hydrogel of the present invention
[0063] 1. Experimental methods
[0064] The CHA-GOx / MnO2-PDA hydrogel synthesized above was used to generate the ions at different powers (1, 1.25, 1.5 W / cm 2 ) near-infrared light (808nm wavelength) was irradiated for 5 minutes, and the temperature increase images were collected by a thermal imaging instrument.
[0065] 2. Experimental results
[0066] The experimental results are as follows Figure 4 As shown in the figure: Under the irradiation of near-infrared light (wavelength of 808nm), the hydrogel shows a characteristic of gradually increasing temperature. The temperature increase pictures are collected every 30s using a thermal imager. For the same hydrogel, different irradiation powers (1, 1.25, 1.5W / cm 2 ) under the heating characteristics, and finally choose 1.25W / cm 2 The irradiation intensity under power was finally stabilized at 42°C.
[0067] The experimental results show that the multifunctional hydrogel of the present invention has controllable photothermal responsiveness at 1.25 W / cm 2 It can maintain a mild temperature (42°C) for a long time under the irradiation intensity of high power.
[0068] Experimental Example 2: Anti-tumor performance test of the photothermal responsive multifunctional hydrogel of the present invention
[0069] 1. Experimental methods
[0070] The Gel / PDA-GM synthesized above is used as the CHA-GOx / MnO2-PDA hydrogel in Example 1 synthesized above.
[0071] K7M2 cells were treated with different hydrogels or solutions for 24 h. The laser treatment involved near-infrared light (808 nm wavelength) at 1.25 W / cm 2 Irradiate the gel at 400 MHz for 5 min before adding samples.
[0072] The experiment was divided into eight groups, and the treatment methods for each group were as follows:
[0073] The first group, i.e., the NC group, was treated with CHA gel (concentration: 100 μl of prepared gel in 1 ml of culture medium);
[0074] The second group, i.e., Gel+laser group, was treated with laser treatment + CHA gel (concentration: 100 μl of prepared gel in 1 ml of culture medium);
[0075] The third group, i.e., the Gel / PDA group, was treated with Gel / PDA gel (concentration: 100 μl of prepared gel in 1 ml of culture medium);
[0076] The fourth group, namely the MnO2 group, was treated with MnO2 nanoparticles aqueous dispersion (concentration 3 mg / ml);
[0077] The fifth group, the GOx group, was treated with GOx solution (concentration 1 mg / ml);
[0078] The sixth group, the GM group, was treated with GM nanoparticle dispersion (concentration 1 mg / ml);
[0079] The seventh group, i.e., the Gel-GM group, was treated with Gel-GM gel (concentration: 100 μl of the prepared gel in 1 ml of culture medium);
[0080] The eighth group, namely the Gel / PDA-GM+laser group, was treated with laser treatment plus treatment with the Gel / PDA-GM gel prepared in Example 1 (concentration: 100 μl of the prepared gel added to 1 ml of culture medium).
[0081] The above concentrations are final concentrations.
[0082] Finally, live and dead cell staining was used to verify its effect on tumor cells, with live cells being stained green and dead cells being stained red.
[0083] 2. Experimental results
[0084] Depend on Figure 5 It can be seen that the hydrogel of the present invention has the advantage of synergistically killing tumor cells.
[0085] Experimental Example 3: Test on the osteogenic differentiation performance of the photothermal responsive hydrogel of the present invention
[0086] 1. Experimental methods
[0087] MC-3T3 cells were treated with different hydrogels for 24 h. Among them, laser treatment involved near-infrared light (808 nm wavelength) at 1.25 W / cm 2 Irradiate the gel at 400 MHz for 5 min before adding samples.
[0088] The experiment was divided into three groups, and the treatment methods for each group were as follows:
[0089] The first group, i.e., the Control group, was treated with CHA gel (concentration: 100 μl of prepared gel in 1 ml of culture medium);
[0090] The second group, namely the Gel / PDA-MnO2 group, was treated by adding Gel / PDA-MnO2 gel (concentration: 100 μl of the prepared gel in 1 ml of culture medium).
[0091] The third group, namely the Gel / PDA-MnO2+laser group, was treated with laser treatment + Gel / PDA-MnO2 gel (concentration: 100 μl of prepared gel added to 1 ml of culture medium) treatment.
[0092] The above concentrations are final concentrations.
[0093] Finally, the osteogenic differentiation was verified by ALP, ARS staining and qPCR experiments.
[0094] 2. Experimental results
[0095] Depend on Figure 6 It can be seen that the photothermal responsive hydrogel of the present invention can effectively promote the ALP expression and calcium nodule formation of cells when combined with mild light. The experimental results show that the photothermal responsive hydrogel of the present invention has the effect of promoting the osteogenic differentiation of cells.
[0096] Experimental Example 4: Biocompatibility performance test of the photothermal responsive hydrogel of the present invention
[0097] 1. Experimental methods
[0098] The extracts collected after 24 hours of co-culture of CHA gel, Gel / PDA gel and an equal volume of cell culture medium were used as 100% mother solution, and then diluted to 50%, 20%, 10%, 1% according to the proportion, and 0% was used as blank culture medium control. The effect of the extracts on the viability of K7m2 and 3T3 cells was tested using cck8.
[0099] 2. Experimental results
[0100] The experimental results are as follows Figure 7 As shown: After being treated with the photothermal responsive hydrogel extract, the viability of the cells is almost unaffected, indicating that the material itself has no effect on the cells, which also provides a basis for the clinical transformation of the material.
[0101] The present invention has developed a photoresponsive multifunctional composite hydrogel platform for in situ bone tumor treatment, recurrence prevention and bone reconstruction, which has the following obvious advantages: (1) Encapsulated manganese dioxide@glucose oxidase nanoparticles use the differences in biological characteristics between tumor and normal cells to achieve tumor targeting, selectively destroy tumor energy supply, reduce tumor hypoxia, and enhance photothermal response; (2) Combined with starvation therapy and mild photothermal therapy, synergistically kill tumors and prevent recurrence; (3) Based on the differences in biological characteristics between tumor cells and normal cells, intelligent targeting design, local effects of hydrogels, platform biocompatibility, and safe low-power near-infrared light excitation, side effects are minimized; (4) Long-term maintenance of mild temperature (42°C) during tumor treatment is conducive to ideal osteogenesis, which is of great significance for clinical application. This innovative therapeutic hydrogel platform not only inspires strategies to inhibit tumor growth and prevent postoperative recurrence, but also has important reference value for patients without surgical indications or with individualized needs.
Claims
1. A photothermal responsive multifunctional hydrogel, Features: The hydrogel is prepared from chitosan or its derivatives, alginate, hyaluronate, manganese dioxide@glucose oxidase, polymerized dopamine and calcium salt as raw materials; wherein the manganese dioxide@glucose oxidase is a product prepared from manganese dioxide and glucose oxidase as raw materials; and the mass ratio of the chitosan or its derivatives, alginate, hyaluronate, manganese dioxide@glucose oxidase, polymerized dopamine and calcium salt is (5-10): (2-5): (0.05-1): (4-8): (0.5-4): (10-50).
2. The photothermal responsive multifunctional hydrogel according to claim 1, Features: The chitosan derivative is carboxymethyl chitosan, the alginate is sodium alginate, the hyaluronate is sodium hyaluronate, and the calcium salt is calcium chloride.
3. The photothermal responsive multifunctional hydrogel according to claim 1, Features: The manganese dioxide@glucose oxidase is manganese dioxide@glucose oxidase nanoparticles, and the polymerized dopamine is polymerized dopamine nanoparticles.
4. The photothermal responsive multifunctional hydrogel according to claim 3, Features: The preparation method of the manganese dioxide@glucose oxidase nanoparticles comprises the following steps: mixing a manganese dioxide nanoparticle solution with a glucose oxidase solution, reacting to obtain manganese dioxide@glucose oxidase nanoparticles, wherein the mass ratio of the manganese dioxide nanoparticles to the glucose oxidase is (4-8):
1.
5. The photothermal responsive multifunctional hydrogel according to claim 4, Features: The mass ratio of the manganese dioxide nanoparticles to the glucose oxidase is 6:
1.
6. The photothermal responsive multifunctional hydrogel according to claim 5, Features: The manganese dioxide nanoparticles are products obtained by the reaction of polycyclic aromatic hydrocarbons and potassium permanganate.
7. The photothermal responsive multifunctional hydrogel according to any one of claims 1 to 6, Features: The mass ratio of the chitosan or its derivative, alginate, hyaluronate, manganese dioxide@glucose oxidase, polymerized dopamine and calcium salt is 8:3.4:0.2:6:1.6:
30.
8. A method for preparing the photothermal responsive multifunctional hydrogel according to any one of claims 1 to 7, Features: It includes the following steps: (1) mixing chitosan or its derivatives and manganese dioxide@glucose oxidase in an aqueous solution to obtain a first mixed solution; (2) mixing alginate and polymerized dopamine in an aqueous solution to obtain a second mixed solution; (3) The first mixed solution is mixed with the second mixed solution, and hyaluronate and calcium salt are added to obtain a photothermal responsive multifunctional hydrogel after reaction.
9. Use of the photothermal responsive multifunctional hydrogel according to any one of claims 1 to 7 in preparing bone tissue repair materials.
10. Use of the photothermal responsive multifunctional hydrogel according to any one of claims 1 to 7 in preparing a drug for treating bone tumors.
Citation Information
Cited By
RB (at) PDA hydrogel precursor for treating skin infection as well as preparation method and application of RB (at) PDA hydrogel precursor
CN121337725A
